Digital Health & Health Tech
HIPAA-compliant monitoring for digital health platforms processing PHI
Digital health companies face HIPAA BA obligations, FDA device security requirements, and SOC 2 demands from hospital customers — simultaneously. ManySignal monitors PHI access, SaMD infrastructure, and business operations in a single BAA-ready platform.
BAA
Business Associate Agreement available for all health-tech customers
60 days
HIPAA Breach Notification Rule deadline — tracked automatically
FDA 2023
Cybersecurity guidance for SaMD manufacturers — Section 524B FD&C Act
SOC 2 + HIPAA
Both frameworks monitored and evidenced simultaneously
How ManySignal protects health-tech companies
HIPAA as a Business Associate — monitoring for SaaS health platforms
Digital health companies that process PHI for covered entities operate as Business Associates under HIPAA. ManySignal monitors access to PHI within the platform, detects anomalous data access patterns, and provides the breach detection and notification evidence required under the HIPAA Breach Notification Rule. The BAA-compliant deployment ensures PHI is processed within HIPAA-eligible infrastructure.
- PHI access logging and anomaly detection within health platform
- Breach detection with 60-day notification countdown
- HIPAA-eligible AWS infrastructure with AES-256 encryption
HIPAA as a Business Associate — monitoring for SaaS health platforms
FDA SaMD and connected device security monitoring
Digital health companies producing Software as a Medical Device (SaMD) must comply with FDA's cybersecurity guidance for medical devices (2023). ManySignal monitors the device management infrastructure and update mechanisms for SaMD products — detecting unauthorised firmware updates, abnormal device communication patterns, and API abuse against the health platform backend.
- SaMD device management API access baselining
- Firmware update anomalies — unexpected source, timing, or scope
- Device-to-cloud communication pattern monitoring
FDA SaMD and connected device security monitoring
Investor and patient data protection for digital health startups
Digital health companies hold patient health data, investor term sheets, clinical partnership agreements, and FDA submission materials — all simultaneously. ManySignal monitors access to sensitive business and patient data in a single platform, applying appropriate access controls and anomaly detection without requiring separate tools for clinical data vs. business data.
- Unified monitoring across clinical data, investor data, and business operations
- Post-Series funding access control verification — new employee onboarding risks
- M&A target data access monitoring during due diligence periods
Investor and patient data protection for digital health startups
Regulatory frameworks supported
Health tech security — common questions
Does ManySignal sign BAAs for digital health companies processing PHI?
Yes. ManySignal executes BAAs with digital health companies operating as Business Associates under HIPAA. The BAA is available at /legal/baa. All PHI processed by ManySignal on behalf of health-tech customers is handled in HIPAA-eligible AWS infrastructure with AES-256 encryption at rest, TLS 1.3 in transit, and strict access controls on ManySignal staff access.
How does ManySignal address FDA cybersecurity requirements for digital health companies?
The FDA's 2023 cybersecurity guidance for medical devices (Section 524B of the FD&C Act) requires manufacturers to monitor for post-market cybersecurity vulnerabilities and to have a plan for reporting exploited vulnerabilities. ManySignal monitors SaMD backend infrastructure and device management platforms, and provides the post-market surveillance evidence required for FDA premarket submissions and 510(k) applications.
Can ManySignal support the monitoring needs of a 20-person digital health startup?
Yes. ManySignal scales from startup to enterprise. For a 20-person digital health company with a single cloud environment and an AWS-hosted health platform, ManySignal can be fully deployed in under two hours. The triage agent handles alert volume without requiring dedicated security staff — many early-stage health-tech companies operate with ManySignal as their only security platform before hiring their first security engineer.
What is the difference in monitoring requirements between a consumer health app and a B2B health platform?
Consumer health apps (Direct-to-Consumer) may not involve covered entities, so HIPAA BA obligations may not apply — but state health data laws (My Health My Data Act in Washington, Nevada, and others) create equivalent obligations. B2B health platforms with covered entity customers are Business Associates and face full HIPAA obligations. ManySignal applies the appropriate monitoring profile based on your customer contracts and data classification.
How does ManySignal handle SOC 2 Type II for health-tech companies that need both SOC 2 and HIPAA?
ManySignal provides continuous monitoring evidence for both frameworks simultaneously. SOC 2 CC controls and HIPAA §164.312 requirements are both mapped and evidenced in parallel. At audit time, the platform produces separate evidence packages formatted for the SOC 2 auditor and for HIPAA compliance review — avoiding the double effort most health-tech companies face when managing these frameworks separately.
Start with a BAA and a demo
We'll execute the BAA, connect your AWS environment and health platform logs, and show you PHI access monitoring and breach detection evidence — all in your first session.